Assessing AML-based risk criteria in patients with accelerated/blastphase MPN treated with less-intensive therapy Research Letter


Authors: Shaw, R.; Yoon, J. J.; Johnston, H.; Davidson, M. B.; Siddon, A. J.; Shallis, R. M.; Chen, E. C.; Burkart, M.; Oh, T. S.; Iyer, S. G.; Madarang, E.; Muthiah, C.; Kassner, J.; Rampal, R. K.; Murthy, G. S. G.; Bradley, T.; Abaza, Y.; Garcia, J. S.; Gupta, V.; Pettit, K. M.; Odenike, O.; Patel, A. A.
Title: Assessing AML-based risk criteria in patients with accelerated/blastphase MPN treated with less-intensive therapy
Keywords: adult; clinical article; controlled study; aged; gene mutation; follow up; letter; cohort analysis; protein p53; intensive care; allogeneic hematopoietic stem cell transplantation; myeloproliferative neoplasm; isocitrate dehydrogenase; acute myeloid leukemia; human; male
Journal Title: Blood Advances
Volume: 9
Issue: 10
ISSN: 2473-9529
Publisher: American Society of Hematology  
Date Published: 2025-05-27
Start Page: 2453
End Page: 2457
Language: English
DOI: 10.1182/bloodadvances.2024015712
PUBMED: 39969200
PROVIDER: scopus
DOI/URL:
Notes: Letter -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Raajit Kumar Rampal
    338 Rampal
  2. James Yoon
    1 Yoon